Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders,...
Phase 1 Trial
CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors
1 min read
CDR-Life Inc. today announced the clearance of an Investigational New Drug (IND) application with the U.S. Food and...
